THE COMMITTEE ON ENERGY AND COMMERCE
November 12, 2012
MAJORITY MEMORANDUM
TO: Members, Subcommittee on Oversight and Investigations
FROM: Subcommittee on Oversight and Investigations Staff
RE: Hearing on “The Fungal Meningitis Outbreak: Could It Have Been Prevented?”
On Wednesday, November 14, 2012, at 10:00 a.m. in room 2123 of the Rayburn House Office Building, the Subcommittee on Oversight and Investigations will hold a hearing entitled “The Fungal Meningitis Outbreak: Could It Have Been Prevented?”
This hearing will examine the facts surrounding the recent outbreak of fungal meningitis and other infections linked to contaminated injectable products made and distributed by the New England Compounding Center (NECC) in Framingham, Massachusetts. This hearing will also examine the history of complaints associated with NECC and its affiliated entities as well as related inspections and actions taken by the U.S. Food and Drug Administration (FDA) and the Massachusetts Department of Public Health (MDPH).
I. WITNESSES
Panel One
Ms. Joyce Lovelace
Panel Two
Mr. Barry J. Cadden
President, Co-Owner and Director of Pharmacy
New England Compounding Center
continue reading here
No comments:
Post a Comment